Biogen Inc. (NASDAQ:BIIB) shares rose 10% Thursday after the company reported positive results from its Phase 2 CELIA study of diranersen, an experimental Alzheimer’s treatment targeting tau protein.
CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, ...
Only about 10% to 15% of patients with this type of brain cancer survive up to 2 years. An adjuvant personalized DNA vaccine ...
Wes Streeting has moved on. What did he achieve after nearly two years in the job, and what might his departure mean for the ...
GTB-5550 is now the 3rd TriKE® to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 ...
Roblox has hired its first-ever chief growth officer as it builds toward its goal of capturing 10% of the global gaming ...
NextSource Materials Inc. (TSX:NEXT, OTCQB:NSRCF) received a delegation from Germany's Federal Institute for Geosciences and ...
Traffic lanes will shift and close near exit 261 on Interstate 64 as early as May 17 when Virginia Department of ...
For many guys – myself very much included – the quest to build bigger, stronger and injury-proof shoulders can be a lifelong ...
Archer Aviation, Rigetti Computing, and SoundHound AI, three of the most-watched speculative names, have rallied off April ...
New federal cybersecurity rules will be costly to Colorado businesses, but the governor can help bridge a funding gap this summer.
Schools in temporary accommodation will be given priority under the next phase of the National Development Plan, Minister for Education and Youth Hildegarde Naughton has said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results